The StarPhoenix on MSN
'There was really no option': Son of father with dementia speaks out about inappropriate antipsychotic use
“There was really no option. This was their method of containing a person,” Guenter said. Before the drugs, Guenter found his ...
The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...
ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.
Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized ...
14don MSN
Rare side effects of antipsychotic medications provide new evidence for safer global prescribing
Patients with severe mental illnesses, such as schizophrenia and bipolar disorder, often require long-term use of ...
The diabetes drug metformin can help kids manage weight gain associated with bipolar drugs. Children taking metformin were ...
Stocktwits on MSN
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder
The new approval is the first for the drug under JNJ leadership. ・The drug is also approved for the treatment of bipolar I ...
An Oklahoma doctor says ivermectin can be dangerous for people who feel “bugs” on their skin, urging medical evaluation for ...
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality.
A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...
News-Medical.Net on MSN
Researchers identify patient response patterns to novel schizophrenia medication
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results